‘Another burden’: RACGP rejects proposed PBS restrictions on diabetes drugs
Changes to clinical criteria could lead to confusion for prescribers, says Dr Gary Deed
The RACGP has rejected calls for the PBS listing for initiating GLP-1 receptor agonists to move to authority required amid concerns it will add to GPs’ workload.
At its most recent meeting in March, the PBAC published draft recommendations following a review of the PBS criteria for diabetes medications.
